JEAN R FLEURINOR

Allopathic & Osteopathic Physicians|General Practice CLEWISTON, FL NPI 1750436382

General Payments — all program years on this page

$3,333.54

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 152
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $558.95 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $558.9519

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $89.026
2019 $244.7916
2020 $291.8820
2021 $700.6334
2022 $780.8830
2023 $667.3927
2024 $558.9519

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086156490 Bayer Healthcare Pharmaceuticals Inc. $22.79 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086161186 Bayer Healthcare Pharmaceuticals Inc. $21.47 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086254356 Bayer Healthcare Pharmaceuticals Inc. $20.91 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086257040 Bayer Healthcare Pharmaceuticals Inc. $18.45 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096654165 Novo Nordisk Inc $14.06 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096722335 Novo Nordisk Inc $14.15 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104265667 AstraZeneca Pharmaceuticals LP $110.82 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104290438 AstraZeneca Pharmaceuticals LP $25.50 03/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104601386 AstraZeneca Pharmaceuticals LP $18.48 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105380415 AstraZeneca Pharmaceuticals LP $125.00 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105616679 AstraZeneca Pharmaceuticals LP $15.15 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115822405 GlaxoSmithKline, LLC. $18.35 03/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116184817 GlaxoSmithKline, LLC. $20.78 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116540013 GlaxoSmithKline, LLC. $20.10 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116678119 GlaxoSmithKline, LLC. $20.32 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118139140 Boehringer Ingelheim Pharmaceuticals, Inc. $14.69 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125240962 Abbott Laboratories $20.39 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135034430 Lilly USA, LLC $19.60 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141690436 Merck Sharp & Dohme LLC $17.94 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.